Publications by authors named "B Van Dijkman"

Context: Breast development is an important outcome for trans women receiving gender affirming hormone therapy (GAHT). Limited breast development has been reported, possibly because of testosterone exposure during puberty. The impact of puberty suppression (PS) on breast development is unclear.

View Article and Find Full Text PDF

Background: Medical consultations with older patients often include triadic conversations and decision-making processes involving physicians, patients, and family members. The presence of family members may change the communication dynamics and therefore increase the complexity of the consultation and decision-making process.

Objective: This study explored associations between physicians' shared decision-making (SDM) behaviour and patients' and family members' participation in the decision-making process.

View Article and Find Full Text PDF

Three-dimensional (3D) imaging techniques are promising new tools for measuring breast volume, for example in gender-affirming therapy. Transgender individuals can be treated with gender-affirming hormone therapy (GAHT). A robust method for monitoring breast volume changes is critical to be able to study the effects of feminizing GAHT.

View Article and Find Full Text PDF

Introduction: There is a growing interest in the involvement of family members of older patients with cancer in decision-making processes. The aim of this study is to identify how and to what extent family members, together with patients and physicians, are involved in triadic decision-making processes in clinical practice.

Materials And Methods: This study was conducted using an exploratory observational design.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of adding oral progesterone to traditional gender-affirming hormone therapy (GAHT) with estradiol in transgender women on breast volume post surgery.
  • It employs a randomized controlled trial design, where 90 participants are divided into six groups receiving varying doses of estradiol and progesterone for 12 months.
  • Key measurements include changes in breast volume using 3D imaging, alongside assessments of safety, mood, sleep, and sexual pleasure.
View Article and Find Full Text PDF